|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02389 BJ HEALTH
Nominal 
0.074 0.000 (0.000%) | 2024/12 - Final HKD(K$) | %Chg (Compare to Final) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | |
| Turnover | 149,945 | 6.840% | 140,346 | 166,484 | 203,776 | 149,887 |
| Cost of Sales | (114,265) | 12.165% | (101,872) | (119,972) | (156,785) | (117,095) |
| Gross Profit | 35,680 | -7.262% | 38,474 | 46,512 | 46,991 | 32,792 |
| 2024/12 - Final HKD(K$) | %Chg (Compare to Final) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (5,751) | -62.072% | (15,163) | (10,109) | (7,030) | (33,960) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (30,434) | 32.207% | (23,020) | (43,498) | (17,885) | (43,280) | |
| Profit / (Loss) before Taxation | (119,421) | 73.633% | (68,778) | (102,696) | (46,619) | (200,710) | |
| Taxation | 3,846 | -45.501% | 7,057 | 3,891 | 6,385 | 721 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (643) | 299.379% | (161) | 1,109 | 824 | 14,665 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (116,218) | 87.806% | (61,882) | (97,696) | (39,410) | (185,324) | |
| 2024/12 - Final HKD(K$) | %Chg (Compare to Final) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | |
| Net Finance Costs / (Income) | (4,617) | -69.687% | (15,231) | (12,990) | (18,412) | (29,444) |
| Depreciation & Amortisation | 21,721 | -10.285% | 24,211 | 26,007 | 34,181 | 31,924 |
| Directors' Emoluments | 8,083 | 24.526% | 6,491 | 5,707 | 6,820 | 6,541 |
| 2024/12 - Final | %Chg (Compare to Final) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2024/12 - Final | %Chg (Compare to Final) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| EPS (cts) | -1.920 | 90.099% | -1.010 | -1.610 | -0.650 | -3.050 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | (0.006) | -- | (0.007) | (0.005) | (0.003) | 0.001 |
| NBV per share ($) | 0.283 | -- | 0.311 | 0.336 | 0.377 | 0.375 |
| Remarks: | Real time quote last updated: 28/10/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD -29,236 |
| %Change | -48.173% |
| EPS / (LPS) | HKD -0.005 |
| NBV Per Share ($) | HKD 0.279 |